Author name: [email protected]

Modern healthcare is full of contradictions. On one hand, it’s a high-performing economic powerhouse—one of the most profitable and resilient sectors globally. On the other, it’s overseeing a population that is, by many measures, becoming sicker. Chronic disease rates are rising. Preventable illnesses are commonplace. And yet, healthcare spending continues to grow. This tension raises […]

For decades, Nicotinamide N-Methyltransferase (NNMT) flew under the radar—regarded as a minor player in cellular metabolism. But science evolves, and so does our understanding of metabolic regulation. Today, NNMT is rapidly gaining attention as a critical mediator of energy balance, epigenetics, and age-related disease processes. NNMT is a cytosolic enzyme that catalyzes the methylation of

Peptide therapy threatens to revolutionise therapeutics — not with noise, but with precision, intelligence, and biocompatibility. It’s a little-known paradigm that differs significantly from the small-molecule pharmaceuticals most of us were trained to use or prescribe. But it’s gaining momentum fast. The word peptide refers to the chemical structure of these molecules: short chains of

None of the villains self-identify as such.  There is a fundamental injustice at the heart of healthcare regulation. Like all injustices, it stems from a mismatch between rights and responsibilities. Those who hold power often lack the responsibility (accountability) to use it wisely, while those who bear the responsibility for outcomes frequently lack the power

Medicinal Cannabis is no longer on the fringe. Chronic pain, anxiety, insomnia, epilepsy, and palliative care support are amongst a growing list of evidence-based recommendations for this natural therapeutic modality. Over the past decade, it has transformed from a controversial therapy into a science backed treatment option. Regulators are responding to the demand from patients

A recent French study has confirmed what many in functional and integrative medicine have long suspected: high-dose vitamin D supplementation significantly reduces disease activity in early multiple sclerosis (MS).   The D-Lay MS trial, the largest of its kind, demonstrated that patients with clinically isolated syndrome (CIS)—the earliest detectable stage of MS—experienced a statistically significant

Australia’s healthcare system is burdened not by a lack of talent or resources, but by an increasingly suffocating layer of bureaucracy. The Therapeutic Goods Administration (TGA), AHPRA, and state health departments—once intended as stewards of public safety—have morphed into self-replicating ecosystems more focused on regulating process than improving outcomes. Our patients are sicker than ever.

We typically reserve the term “epidemic” for outbreaks of infectious disease—something contagious and acute. The real epidemic of our time isn’t viral at all – it is chronic. The rates of chronic disease are rising everywhere. Diabetes, cancer, dementia, cardiovascular and neurodegenerative conditions are becoming not only more common—but they’re showing up earlier, with patients

We are living through an era of unprecedented chronic disease. Adults and children alike are becoming sicker, younger, and more frequently. Conditions like obesity, diabetes, cardiovascular disease, autoimmune disorders, and mental health challenges are growing steadily, year on year. Our healthcare system, however, seems locked into an outdated paradigm—one focused not on health, but on